Western IRB WIRB - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

Western IRB WIRB

Description:

... safety and efficacy of a drug, device, diagnostic, treatment, intervention or ... research that must be conducted under the purview of the Insitutional Biosafety ... – PowerPoint PPT presentation

Number of Views:18
Avg rating:3.0/5.0
Slides: 26
Provided by: res98
Category:
Tags: irb | wirb | western

less

Transcript and Presenter's Notes

Title: Western IRB WIRB


1
Western IRB (WIRB)
All you need to know as a GWU investigator
  • Irb forum - January, 11 2007
  • GWU Office of Human Research
  • Ross Hall, Suite 613

2
Why is GWU outsourcing to wirb?
  • To ensure that all industry sponsored trials are
    reviewed carefully and in full compliance with
    all state and federal laws.
  • To ensure studies receive an IRB review are
    reviewed in a timely manner.

3
Will this affect GWUs Federal Wide Assurance
(FWA)?
  • Using WIRB will not change GWUs obligations
    under its existing FWA.
  • GWU remains responsible for ensuring compliance
    with the IRBs determinations and with the Terms
    of its FWA. GWU OHR will continue to ensure this
    through the Post Approval Monitoring Program.
  • WIRB will report its findings and actions to
    appropriate officials at GWU.

4
What research activities will be eligible for
review by wirb?
  • Only new industry-sponsored clinical trials are
    eligible to be reviewed by WIRB.

5
What is an industry-sponsored clinical trial?
  • Protocol for the project is designed and written
    by a pharmaceutical or device sponsor or another
    for profit entity/company that holds
    the INDs/IDEs for the protocol.
  • A controlled study involving human subjects,
    designed either to
  • test drugs, devices, diagnostics, treatments,
    interventions or preventative measures including
    testing for an unapproved indication,
  • evaluate the safety and effectiveness of new
    drugs, devices, diagnostics, treatments,
    interventions or preventative measures or
  • collect data to increase knowledge that would
    lead to enhanced safety and efficacy of a drug,
    device, diagnostic, treatment, intervention or
    preventative measure, AND

6
Types of research not eligible for review by Wirb
  • planned emergency research
  • Xenotransplantation
  • gene transfer
  • embryonic stem cell research
  • investigator-initiated research (regardless of
    funding source)
  • research that must be conducted under the purview
    of the Insitutional Biosafety Committee (IBC) or
    Radiation Safety Committee.

7
What to submit to Ohr prior to sending the
studies to WIRB?
  • You must register studies in the OHR prior to
    submitting to WIRB.
  • Submit a copy of
  • Completed WIRB Initial Submission Form
  • GWU OHR WIRB Sign-Off Sheet with the PIs
    original signature (this may be scanned or hard
    copy original)
  • Submit via e-mail to ohrirb_at_gwumc.edu or via hard
    copy to Ross Hall, Suite 613.
  • A GWU IRB will be assigned to the study and the
    signed GWU OHR WIRB Sign-Off Sheet will be
    returned to you via e-mail as a PDF. This form is
    part of the required documents submitted to WIRB.
    WIRB will not review the study unless they
    receive the GWU OHR WIRB Sign-Off Sheet.

8
GWU Sign Off Sheet To be signed by both the PI
and OHR designee. This form will soon be
available on the OHR website. This may be
submitted as a PDF via e-mail or as a hard
copy. This document MUST have the original PIs
signature
9
WIRB Websitewww.WIRB.com
  • All forms for WIRB are located on their web page.
  • If you have any questions about the forms you may
    contact either WIRB or OHR and we will be glad to
    assist you.
  • WIRB Contact
  • Phone (360) 252-2500 or 1-800-562-4789
  • E-mail clientservices_at_wirb.com
  • OHR Contact
  • Phone 202-994-2715
  • E-mail OHRIRB_at_gwumc.edu

10
WIRB INITIAL SUBMISSION FORM Located on the web
at www.WIRB.com All forms are downloadable in
both PDF and Word format.
11
What about other research studies?
  • All other university research will be reviewed by
    GWU IRB.
  • All investigator initiated clinical trials
    research, regardless of funding will be reviewed
    by GWU IRB.

12
Is WIRB going to review emergency use?
  • No. However, if an emergency request turns into
    an industry-sponsored clinical trial, then that
    trial can go to WIRB.

Is wirb going to review patient Registries?
  • Yes. However, the primary goal of the registry
    must be to to collect data on long-term safety
    and efficacy, and it must be managed by the
    industry sponsor rather than the GWU.

13
What about the Radiation Safety and/or Biosafety
review for a clinical trial?
  • The GWU OHR will continue to review these aspects
    of all clinical trials.

14
What are the advantages of an outside IRB?
  • The turn-around time for review and approval
    may be much faster.
  • Conflict of interest is eliminated.
  • With decreased administrative burden, GWU OHR
    staff can dedicate additional resources to
    quality improvement activities associated with
    the human subjects protections program

15
What are the fees charged by WIRB?
  • WIRB charges a separate fee for each review
    activity
  • initial review
  • continuing review
  • review of modifications
  • See the WIRB Fee Schedule available on line
  • http//www.wirb.com/shell.php?contentcontent/wirb
    _services_irbservices_fees

16
Who pays the WIRB fees? are those fees
negotiated as part of the contract with the
sponsor?
  • GWU and the GWU-IRB are not responsible for
    paying fees associated with WIRB review
    activities.
  • Researchers should arrange payment directly with
    the industry sponsor. WIRB can bill the sponsor
    directly. WIRB fees are NOT negotiated or
    referenced in any agreements between the GW
    Office of Research Services and sponsors.

17
What if the sponsor refuses to pay the WIRB fees?
  • If the sponsor refuses to pay the billed amounts
    after the study has been reviewed by WIRB, the
    investigator or his/her department will be
    responsible for the fees.
  • Please note
  • The financial specifics of the contract are
    still being negotiated.

18
What if my sponsor requires review by a local IRB?
  • The agreement between
  • GWU and WIRB anticipates
  • that WIRB will undertake activities to allow it
    to assure knowledge of the GWU local research
    context.

19
Can I use the wirb consent form templates?
  • Yes, you may use either the GWU or WIRB
    templates. However, there is required
    information from the GWU template that must be
    added to the WIRB document. This is underlined
    in the GWU template.

What about HIPAA?
  • Use the GWUMC HIPAA forms, and include them in
    your application packet to WIRB. They will be
    reviewed and approved by WIRB.

20
If I need a Certificate of Confidentiality, who
signs it?
  • The GWU Institutional Official. Send these
    requests to the Office of Health Research in Ross
    Hall, Suite 712

How can I document training completion for WIRB?
  • You must obtain training through the GWU
    web-based CITI program. WIRB will verify your
    completion by communication with the GWU OHR.

21
After receiving WIRB approval, what about
modifications?
  • You may apply directly to WIRB, without going
    through the GWU OHR. Use the appropriate forms
    and instructions that are posted on the WIRB web
    site

22
Where do I send adverse event reports or reports
of unanticipated problems?
  • Send them to WIRB
  • Use forms provided on the WIRB web site.
  • If you are reporting an on-site adverse event
    that is unexpected and serious, report them to
    WIRB and send a copy to the GWU OHR, within 24
    hours.

23
If my trial is placed on hold, suspended, or
terminated, should I notify the GWU OHR?
  • Yes. The GWU OHR must be notified immediately.
  • It does not matter whether the hold, suspension,
    or termination was initiated by the researcher,
    WIRB, the sponsor, the FDA, or any other agency.

24
Who should subjects contact if they have
concerns, questions, or complaints?
  • They may contact the GWU Human Protections
    Administrator. This is stated in the research
    consent form contact information.

25
  • Questions?
  • Thank you!
  • Please join us next month on 2/8/2007
  • Our topic will be
  • EXEMPT Research
Write a Comment
User Comments (0)
About PowerShow.com